Wissenschaftliche Arbeiten

Prof. Dr. Nedim Turan

110 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?

    Medicina, 2024

    DOI 10.3390/medicina60081372 PMID 39202652 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  2. Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study

    Medicina, 2024

    DOI 10.3390/medicina60071088 PMID 39064516 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  3. Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer: A Promising Strategy for Enhanced Progression-Free Survival Post Ado-Trastuzumab Emtansine Progression

    Medicina, 2024

    DOI 10.3390/medicina60122069 PMID 39768949 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  4. Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive Therapy

    Cureus, 2024

    DOI 10.7759/cureus.63362 PMID 39070363 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  5. Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer

    Medicina, 2024

    DOI 10.3390/medicina60060951 PMID 38929568 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  6. Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort study

    Heliyon, 2024

    DOI 10.1016/j.heliyon.2024.e25029 PMID 38317875 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  7. Efficacy and Safety of Ixabepilone in Metastatic Breast Cancer After Multiple Treatments: Analysis Based on Real-World Data

    Journal of Oncological Sciences, 2024

    DOI 10.37047/jos.2024-102164 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  8. Association of Hepatitis-B virus infection status with survival and treatment response in non-small cell lung cancer patients on anti‐pd‐1/pd-l1 therapy

    Journal of Global Antimicrobial Resistance, 2024

    DOI 10.1016/j.jgar.2024.10.248 Frei zugänglicher VolltextQuelle: OpenAlex

  9. Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older

    2024

    DOI 10.20944/preprints202409.0812.v1 Frei zugänglicher VolltextQuelle: ORCID

  10. Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group

    International Journal of Gynecological Cancer, 2024

    DOI 10.1136/ijgc-2024-005419 PMID 38950923 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  11. What alters prognosis in patients who were operated for lung cancer with lymph node metastasis?

    ANZ Journal of Surgery, 2024

    DOI 10.1111/ans.19177 PMID 39205444 1 Zitation (OpenAlex) Quelle: OpenAlex

  12. Which Labarotory Index is Better for Predicting Survival and Pathological Response in Patients with Breast Cancer Receiving NACT?

    Research Square, 2024

    DOI 10.21203/rs.3.rs-3854249/v1 Frei zugänglicher VolltextQuelle: ORCID

  13. Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience

    World journal of urology, 2023

    DOI 10.1007/s00345-023-04482-0 PMID 37351618 3 Zitationen (Europe PMC) Quelle: Europe PMC

  14. Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?

    Medicina Lithuania, 2023

    DOI 10.3390/medicina59030557 PMID 36984558 12 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  15. Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data

    Pancreas, 2023

    DOI 10.1097/mpa.0000000000002238 PMID 37816170 2 Zitationen (Europe PMC) Quelle: ORCID

  16. The association of hemoglobin/red blood distribution width with overall survival: a retrospective analysis of melanoma

    Esperienze Dermatologiche, 2023

    DOI 10.23736/s1128-9155.23.00556-3 1 Zitation (OpenAlex) Quelle: OpenAlex

  17. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center’s experience

    Journal of Chemotherapy, 2021

    DOI 10.1080/1120009x.2021.1923153 PMID 34032198 6 Zitationen (Europe PMC) Quelle: OpenAlex

  18. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/10781552211015762 PMID 33961521 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  19. Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/1078155220924088 PMID 32423326 8 Zitationen (Europe PMC) Quelle: ORCID

  20. Merkel cell carcinoma in Turkey: A multicentric study

    Journal of Cancer Research and Therapeutics, 2021

    DOI 10.4103/jcrt.jcrt_950_19 PMID 34916389 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  21. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?

    Current Problems in Cancer, 2020

    DOI 10.1016/j.currproblcancer.2020.100670 PMID 33129567 1 Zitation (Europe PMC) Quelle: OpenAlex

  22. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.

    PubMed, 2019

    PMID 31786850 1 Zitation (Europe PMC) Quelle: OpenAlex

  23. Outcome of non-metastatic male breast cancer: 222 patients

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz240.024 Frei zugänglicher VolltextQuelle: OpenAlex

  24. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study

    Journal of B U on, 2019

    Quelle: ORCID

  25. P3.01-33 EGFR Mutation in Patients with NSCLC and Its Relationship Between Survival and Clinicopathological Features: An Update Analysis

    Journal of Thoracic Oncology, 2018

    DOI 10.1016/j.jtho.2018.08.1593 Frei zugänglicher VolltextQuelle: OpenAlex

  26. Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreas

    Current Problems in Cancer, 2018

    DOI 10.1016/j.currproblcancer.2018.06.014 PMID 30104029 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  27. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors

    World Journal of Urology, 2017

    DOI 10.1007/s00345-016-1964-6 PMID 27812752 10 Zitationen (Europe PMC) Quelle: ORCID

  28. EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e15028 Frei zugänglicher VolltextQuelle: OpenAlex

  29. Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.15_suppl.e16051 Quelle: ORCID

  30. Prognostic Factors in Stage III Non-Small-Cell Lung Cancer Patients

    Asian Pacific Journal of Cancer Prevention, 2016

    DOI 10.22034/apjcp.2016.17.10.4693 PMID 27893199 22 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  31. Prognostic factors in stage III non-small-cell lung cancer patients

    Asian Pacific Journal of Cancer Prevention, 2016

    DOI 10.7314/apjcp.2016.17.10.4693 Quelle: ORCID

  32. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors

    Tumor Biology, 2015

    DOI 10.1007/s13277-015-3589-6 PMID 26026587 5 Zitationen (Europe PMC) Quelle: OpenAlex

  33. The prognostic value of lymph node ratio in patients with curatively resected pancreatic adenocarcinoma.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e15238 Frei zugänglicher VolltextQuelle: OpenAlex

  34. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma

    Journal of B U on, 2015

    PMID 25778307 22 Zitationen (OpenAlex) Quelle: ORCID

  35. Gastro-bronchial Fistula, an Uncommon Complication of Transhital Esophagectomy: A Case Report

    Van Yüzüncü Yıl University Academic Data Management System, 2015

    DOI 10.12691/ajcp-3-6-1 Frei zugänglicher VolltextQuelle: OpenAlex

  36. Lomber Omurgaya Yayılan Bir Glioblastoma Multiforme Olgusu

    DergiPark (Istanbul University), 2015

    Quelle: OpenAlex

  37. Prognostic Factors and Adjuvant Treatments for Surgically Treated Cancers of the Biliary Tract: A Multicentre Study of the Anatolian Society of Medical Oncology (ASMO)

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.22.9687 PMID 25520089 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  38. Impact of Adjuvant Treatment Modalities on Survival Outcomes in Curatively Resected Pancreatic and Periampullary Adenocarcinoma

    Annals of Oncology, 2014

    DOI 10.1093/annonc/mdu334.79 PMID 26361410 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  39. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer

    Thoracic Cancer, 2014

    DOI 10.1111/1759-7714.12107 PMID 26763794 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  40. Multicenter epidemiologic study on hepatocellular carcinoma in Turkey

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.6.2923 PMID 24761926 17 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  41. The role of positron emission tomography with 18F-fluorodeoxyglucose in nodal staging of clinical and radiological N0 head and neck cancers

    European Archives of Oto-Rhino-Laryngology, 2013

    DOI 10.1007/s00405-012-2337-4 PMID 23283243 14 Zitationen (Europe PMC) Quelle: OpenAlex

  42. Prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences

    Asian Pacific Journal of Cancer Prevention, 2013

    DOI 10.7314/apjcp.2013.14.11.6287 PMID 24377519 12 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  43. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14533 1 Zitation (OpenAlex) Quelle: OpenAlex

  44. Retrospective analysis of 178 patients with stage I rectum cancer.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14662 Frei zugänglicher VolltextQuelle: OpenAlex

  45. A patient with pleural effusion related to dasatinib,Dasatinib ılişkili plevral efüzyonlu bir hasta

    Erciyes Tip Dergisi, 2013

    DOI 10.5152/etd.2012.41 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  46. Plasma Concentrations of Some Trace Element and Heavy Metals in Patients with Metastatic Colon Cancer

    Journal of Cancer Therapy, 2013

    DOI 10.4236/jct.2013.46124 24 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  47. Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey

    Thoracic Cancer, 2012

    DOI 10.1111/j.1759-7714.2012.00129.x PMID 28920204 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  48. Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer

    Oncology, 2012

    DOI 10.1159/000342429 PMID 23076023 16 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  49. XELOX versus FOLFOX4 as Second Line Chemotherapy in Advanced Pancreatic Cancer

    Hepatogastroenterology, 2012

    DOI 10.5754/hge12181 PMID 22534542 20 Zitationen (Europe PMC) Quelle: OpenAlex

  50. Front & Back Matter

    Oncology, 2012

    DOI 10.1159/000345789 Quelle: OpenAlex